Cutaneous mucormycosis: an unusual cause of decompensation in a patient with ethanol-related cirrhosis with COVID-19 exposure.
Sherna MenezesJanu Santhosh KumarOmkar S RudraAabha NagralPublished in: BMJ case reports (2022)
We describe a case of cutaneous mucormycosis in a middle-aged man with ethanol-related chronic liver disease. He presented with symptoms of fever, breathlessness for 10 days and altered mental status for 2 days. On admission, he was in septic shock and had acute respiratory distress syndrome (ARDS). He was noted to have ruptured blisters in his left axilla. Although he repeatedly had negative COVID-19 Reverse Transcription-PCR results, he had positive IgG antibodies for COVID-19. He was managed with broad-spectrum antibiotics, steroids, vasopressors and ventilation for ARDS. Over the course of his hospitalisation, the axillary lesion progressed to a necrotising ulcer with deep tissue invasion. Debridement and culture of the axillary ulcer revealed mucor species, and he was started on amphotericin and posaconazole for mucormycosis. Unfortunately, he continued to deteriorate despite aggressive management and died after a prolonged hospital stay of 40 days.
Keyphrases
- acute respiratory distress syndrome
- coronavirus disease
- mechanical ventilation
- extracorporeal membrane oxygenation
- sars cov
- septic shock
- sentinel lymph node
- lymph node
- middle aged
- neoadjuvant chemotherapy
- respiratory failure
- emergency department
- intensive care unit
- ultrasound guided
- case report
- single cell
- radiation therapy
- depressive symptoms
- squamous cell carcinoma
- physical activity
- drug induced
- cell migration
- abdominal aortic aneurysm
- sleep quality
- transcription factor
- brain injury
- rectal cancer